Type I Crigler Najjar syndrome in Tunisia: A study of 30 cases;La maladie de Crigler Najjar de type I en Tunisie: Etude de 30 observations

Tunisie Medicale

Volumn 88, Issue 10, 2010, Pages 707-709

  Aloulou, Hajer ^a   Thabet, Afef Ben ^a   Khanfir, Sonia ^a   Mansour, Lamia Ben ^a   Chabchoub, Imen ^a   Labrune, Phillipe ^b   Kammoun, Thouraya ^a   Hachicha, Mongia ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Child; Crigler Najjar syndrome; Kernicterus; Liver transplantation; Phototherapy

Indexed keywords

GLUCURONOSYLTRANSFERASE;

ARTICLE; CLINICAL ARTICLE; CRIGLER NAJJAR SYNDROME; CRIGLER NAJJAR SYNDROME TYPE 1; EXON; FATALITY; FEMALE; GENE MUTATION; HUMAN; INFANT; JAUNDICE; KERNICTERUS; MALE; NEUROLOGIC DISEASE; RETROSPECTIVE STUDY;

CRIGLER-NAJJAR SYNDROME; FEMALE; GLUCURONOSYLTRANSFERASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PHOTOTHERAPY; RETROSPECTIVE STUDIES; TUNISIA;

EID: 77958149200     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fitouri Z., Barhoumi N., Debbabi R., et al Maladie de Crigler Najjar à propos de 8 cas. Rev Maghr pédiatr, 2002 : 297-301
2. Tabarki B., KhalifaM., Yacoub.M., et al Cerebellar symptoms hearding bilirubinencéphalopathy in Crigler Najjar syndrome. Pediatr neurol, 2002; 27: 234-236
3. Petit FM, Béziau. S, Gajdos.V, et al. The Tunisian population history through the Crigler Najjar syndrome. Eur J Hum Genet. 2008.16: 848-53
4. Bosma P.J Inherited disorders of bilirubin metabolism. J hepatol, 2003;38:107-117.
5. Kappas A., Drummond G.S., Manola T. et al Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production and phototherapy in controlling hyperbilirubinémia in term and near term newborns. Pediatrics, 1995; 95: 468-497
6. Valeas T., Petmezaki S., Henschke C., et al. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with Tin - mesoporphyrin. Pediatrics, 1994; 93: 1-11
7. Lachaux A., Eid B., Stamm D. et al. La transplantation hépatique chez le nourrisson et líenfant à propos de 40 observations. Arch pédiatr, 2000 ; 7 : 369-376.
8. Shauer R., Stangl M., Lang T., et al. Treatment of Crigler Najjar type 1: relevance of early liver transplantation. J pediatr surg, 2003; 38: 1227-1231.
9. Griedelli B., LucianettiA., Gatti S., et al. Orthotopic liver transplantation for Crigler Najjar type I syndrome. Transplant proc, 1997; 29: 440-441.
10. Al Shurafa H., Wali S., Chehab M.S et al. Living related liver transplantation for Crigler Najjar syndrome in Saudi Arabia. Clin transplant, 2002; 16: 222-226
11. Dhawan A, Mitry RR, Hughes RD et al. Hépatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis. 2006; 29:431-5
12. Fox IJ, Chowdhury J R, Kauffman SS et al. Treatement of the Crigler Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338 : 1422-6
13. Roy-Chowdhury N, Kadakol A, Sappal BS et al. Gene therapy for inherited hyperbilirubinemias. J Perinatol.2001; 21: S114-8
14. Bellodi-Privato M, Aubert D, Pichard V, Myara A, Trivin F, Ferry N. Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors. Hepatology. 2005;42:431-8
15. Kaplan M., Hammerman C. Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in interpretation of neonatal serum bilirubin. Clin Chim Acta, 2005; 356: 9-21
16. Shapiro S.M. Bilrubin toxicity in the developing nervous system. Pediatr neurol, 2003; 29: 410-421.
17. Strauss KA, Robinson DL, Vreman HJ et coll. Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr, 2006 ; 165:306-19